The Future of Genomics and Targeted Therapies

Andrey Antov, PhD, MBA

Video Categories: 2018 AONN Midyear

Dr Andrey Antov muses on the evolution of genomics and how it could potentially impact targeted therapies and cancer care.

April 14, 2015

The bioT3 Platform

Dr. Boccia describes the components of the bioT3 platform and its clinical utility in identifying tumor type and actionable targets for therapy.

August 29, 2018

Accurate and Reproducible Measurement of PD-1/PD-L1

Drs. Geoff Oxnard and Lauren Ritterhouse discuss PD-1/PD-L1 as a routine biomarker test run on all lung cancer biopsy specimens, as well as on other selected cancer types, and how qualitative and quantitative results are typically reported.